Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Nov 17, 2016
Franklin Lakes, NJ (November 14, 2016) - BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will host an institutional investor and analyst meeting on Thursday, November 17,...
-
Nov 17, 2016
Earnings Releases / Presentations About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery,...
-
Nov 10, 2016BD to Showcase Latest Advancements at the 16th Annual Diabetes Technology Meeting
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company today announced a new research collaboration supported by JDRF, the leading global organization funding...
-
Nov 8, 2016BD and Lilly Diabetes Collaboration Offers New Delivery Solution for People with Insulin Resistance
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company announced today the launch of the BD(TM) U-500 Insulin Syringe, the first insulin syringe developed for...
-
Nov 3, 2016
Click on the links below to view results for 2016 Third Fiscal Quarter: View document online » PDF File of BD 2016 Third Fiscal Quarter Results » About BD BD is one of the largest global medical...
-
Oct 31, 2016Expands Reproductive and Sexually Transmitted Infections Portfolio with First Test Using Microbiome-based Algorithm for Bacterial Vaginosis Detection
FRANKLIN LAKES, N.J., Oct. 31, 2016 - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) market...
-
Oct 4, 2016Apax Funds to be majority owner of new company, Vyaire Medical
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Apax Partners, today announced the launch of a joint venture - Vyaire Medical - a standalone,...
-
Sep 30, 2016New BD Phoenix(TM) M50 System delivers modularity, reliability, affordability and high-quality susceptibility results needed by clinical microbiology laboratories worldwide
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of its next generation diagnostic instrument for the rapid identification of...
-
Sep 29, 2016The New BD Vacutainer® Barricor(TM) Tube Offers First Major Advance in Plasma Separation Technology in Decades
BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for the BD Vacutainer(®)...
-
Sep 22, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it is investing $100 million in its Holdrege, Neb. facility to expand capacity for its...
-
Sep 21, 2016New BD Veritor(TM) Plus System Enables Fast and Accurate Test Results for Health Care Providers
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of its next generation wireless rapid diagnostic system for detection of...
-
Sep 16, 2016BD ChloraShield(TM) Dressings are Now Available for a Range of Vascular Access Procedures
BD (Becton, Dickinson and Company) (NYSE: BDX) and Vancive Medical Technologies(TM), an Avery Dennison (NYSE: AVY) business, today launched a line of transparent vascular dressings with...
-
Sep 13, 2016BD Obtains FDA Clearance for the BD MAX CT/GC/TV Assay on the BD MAX™ System
FRANKLIN LAKES, N.J., Sept. 13, 2016 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it obtained U.S. Food and Drug...
-
Sep 12, 2016Latest Release of Industry-Leading Pyxis ES platform Advances Enterprise-wide Medication Management and Patient Safety Across Continuum of Care
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced general availability of the latest software release of Pyxis(TM) ES System, delivering...
-
Sep 6, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has submitted a pre-market approval (PMA) application to the U.S. Food and Drug...
-
Sep 1, 2016New Recommendations Based on Findings from Largest-Ever International Survey of more than 13,200 Insulin-Injecting Patients from 42 Countries
The prestigious medical journal, Mayo Clinic Proceedings , today published new insulin delivery recommendations for health care professionals caring for insulin-using patients, including the...
-
Aug 18, 2016Announces $20 Million Investment to Support Growth
SANDY, Utah, Aug. 18, 2016 /PRNewswire/ – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, was joined by senior public officials today to celebrate...
-
Aug 16, 2016Alaris(TM) System Also Cited as Most Comprehensive Infusion Platform
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its Alaris(TM) System infusion platform was cited as having the most customers...
-
Aug 15, 2016
FRANKLIN LAKES, N.J., August 15, 2016 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug...
-
Aug 4, 2016
Click on the links below to view results for 2016 Third Fiscal Quarter: View document online » PDF File of BD 2016 Third Fiscal Quarter Results » About BD BD is one of the largest global medical...
-
Jul 28, 2016
FRANKLIN LAKES, N.J., JULY 26, 2016 – The Board of Directors BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 66 cents per common share, payable on September...
-
Jul 28, 2016
FRANKLIN LAKES, N.J., JULY 28, 2016 – BD(Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that R. Andrew “Andy” Eckert has been...
-
Jul 19, 2016More than 100 Hospitals Have Implemented Interoperability for Alaris(TM) System
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that more than 100 hospitals and health systems have implemented the company's...
-
Jul 1, 2016
FRANKLIN LAKES, NJ July 1, 2016 – BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its third fiscal quarter 2016 earnings conference call on...
-
Jun 16, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a development and global distribution agreement with Check-Points for BD MAX(TM) assays...
-
May 26, 2016First Live Demonstration of the New Cell Sorter at Upcoming CYTO Annual Meeting
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, continues to reinforce its commitment to making flow cytometry easier and more affordable with the...
-
May 5, 2016
Click on the links below to view results for 2016 Second Fiscal Quarter: View document online » PDF File of BD 2016 Second Fiscal Quarter Results » About BD BD is one of the largest global...
-
Apr 26, 2016New BD U-40 Pet Syringes Available at Veterinary Offices
FRANKLIN LAKES, N.J., April 26, 2016 – BD (Becton, Dickinson and Company), a leading medical technology company, announced today that it has launched BD Pet Syringes – veterinary insulin...
-
Apr 22, 2016Genesis(TM) Low Temperature Rigid Sterilization Container System Validated for Modern Low-Temp Sterilization Practices
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new line of surgical instrument sterilization containers that are validated for the...
-
Apr 21, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading medical technology company, announced today that it has sold its vertebral augmentation solutions business, which includes all AVAmax®,...
-
Mar 30, 2016
FRANKLIN LAKES, N.J., Mar. 30, 2016 – BD (Becton, Dickinson and Company), a leading global medical technology company, has obtained 510(k) clearance from the U.S. Food and Drug Administration...
-
Mar 15, 2016Marks sixth year in top spot for infection control and monitoring category
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading medical technology company, announced today that BD MedMined(®) Surveillance Advisor has been named a 2015/2016 Category Leader for...
-
Mar 8, 2016Apax Funds will be majority owner of new company
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a definitive agreement to sell 50.1 percent of its Respiratory Solutions business to...
-
Mar 7, 2016Adds BD Totalys(TM) MultiProcessor and BD Totalys(TM) SlidePrep for Gynecological Specimen Preparation to Cytology Instrumentation Portfolio
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) approval for its BD Totalys(TM)...
-
Mar 6, 2016BD Vacutainer® Barricor™ Tube Designed to Enhance Sample Quality, Improve Laboratory Efficiency and Speed Laboratory Turnaround Time
FRANKLIN LAKES, N.J., March 1, 2016 – BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it obtained the CE mark in Europe for a...
-
Mar 1, 2016
BD Vacutainer® Barricor(TM) Tube Designed to Enhance Sample Quality, Improve Laboratory Efficiency and Speed Laboratory Turnaround Time FRANKLIN LAKES, N.J., March 1, 2016 /PRNewswire/ -- BD...
-
Mar 1, 2016BD Exhibits Next Generation Wireless Diagnostic Test System at #HIMSS16
LAS VEGAS, March 1, 2016 –BD (Becton, Dickinson and Company), a leading global medical technology company, is utilizing AT&T* Internet of Things (IoT) services to connect wireless health...
-
Feb 24, 2016
FRANKLIN LAKES, N.J., Feb. 24, 2016 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the Alaris™ System has been named 2015...
-
Feb 22, 2016
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor healthcare conferences: 2016 RBC...
-
Feb 17, 2016Novel PentaPoint(TM) Comfort and RightGauge(TM) Needle Technologies Help Improve Comfort, Access to Difficult Veins
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and European CE marking...
-
Feb 12, 2016BD CLiC(TM) System is the first, high-throughput, fully integrated, automated bench-top library preparation workflow
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD CLiC(TM) System during the 2016 Advances in Genome Biology and...
-
Feb 8, 2016Innovation Results from Collaboration with the National Institutes of Health
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSymphony(TM) system, a novel cell analyzer enabling the...
-
Feb 5, 2016Revenue increased 16 percent to $1.07 billion
CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its fiscal second quarter, growing revenue in every business line and major...
-
Feb 5, 2016Tests from DiabetOmics to be Integrated into BD Veritor™ Point-of-Care Diagnostic Platform
FRANKLIN LAKES, N.J., Feb. 5, 2016 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has entered into a licensing and distribution...
-
Feb 3, 2016
Click on the links below to view results for 2016 First Fiscal Quarter: View document online » PDF File of BD 2016 First Fiscal Quarter Results » About BD BD is one of the largest global medical...
-
Jan 25, 2016
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 66 cents per common share, payable on March 31, 2016 to holders of record on March 10,...
-
Jan 21, 2016BD leverages Singularity University’s network of solution-shaping experts, faculty, development partners and a highly-engaged global community
MOUNTAIN VIEW, CA and FRANKLIN LAKES, NJ January 21, 2016 – Singularity University (SU), a benefit corporation focused on empowering leaders to leverage exponentially growing technologies to...
-
Jan 15, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 26,...
-
Jan 8, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Fresenius Kabi USA has acquired the BD Rx business, which includes a...
-
Jan 8, 2016
FRANKLIN LAKES, N.J. and LAKE ZURICH, Ill.,January 8, 2016 – Becton, Dickinson and Company (BD) (NYSE: BDX) and Fresenius Kabi USA announced today that Fresenius Kabi has acquired the BD Rx...
-
Jan 7, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its first fiscal quarter 2016 earnings conference call on Wednesday, February 3, 2016, at 8:00...
-
Jan 4, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the 34th Annual J. P. Morgan Healthcare Conference on...
-
Dec 12, 2015State-of-the-Art Research System Optimized for Use with BD Horizon Brilliant(TM) Dyes Is Now Available Worldwide
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSCelesta(TM) flow cytometer during the 2015 American Society...
-
Dec 10, 2015
FRANKLIN LAKES, N.J., Dec. 10, 2015 /PRNewswire/ – CareFusion, a BD company (NYSE:BDX), today announced the U.S. Food and Drug Administration (FDA) has cleared two 510(k)s for its spine...
-
Dec 7, 2015Combined Technologies from BD, CareFusion Create End-to-End IV Management
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a simplified way for hospitals to manage intravenous (IV) medication to help improve...
-
Dec 2, 2015Visit the "BD Leadership Theater" to hear how health systems improve and advance quality and safety across the continuum of care
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company and CareFusion, a BD company, will present its combined, strengthened solutions together as one company,...
-
Nov 23, 2015
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.66 cents per common share, an increase of 10.0 percent from the previous quarter....
-
Nov 12, 2015
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Stifel 2015 Healthcare Conference Tuesday, November 17,...
-
Nov 7, 2015American Association for Respiratory Care (AARC) Presents Award at Annual Congress
TAMPA, Fla., Nov. 7, 2015 /PRNewswire/ – CareFusion, a BD company (NYSE:BDX), was presented today with the Zenith Award for the second year in a row from the American Association for Respiratory...
-
Nov 6, 2015
TAMPA, Fla., Nov. 6, 2015 /PRNewswire/ – CareFusion, a BD company (NYSE:BDX), will be displaying new respiratory solutions that are designed to put patients first, whether ventilated or...
-
Nov 5, 2015AirLife to Offer Nasal High Flow Interfaces from ResMed
SAN DIEGO, CA, Nov. 5, 2015/PRNewswire/ – CareFusion, a BD company (NYSE:BDX), today announced its AirLife business line has signed an exclusive agreement with ResMed (NYSE:RMD) to distribute...
-
Nov 4, 2015- Announces full fiscal year adjusted revenues of $10.302 billion, an increase of 22.0 percent, or 29.5 percent on a currency-neutral basis. On a comparable, currency-neutral basis, adjusted revenues grew 5.3 percent for the full year. As reported, full-year revenues increased 21.7 percent to $10.282 billion.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly adjusted revenues of $3.067 billion for the fourth fiscal quarter ended...
-
Oct 26, 2015Companies to Establish Interoperability between Hemodynamic Monitoring Systems and Infusion Devices
SAN DIEGO and IRVINE, Calif., October 23, 2015 – Edwards Lifesciences and CareFusion, a BD company, today announced a collaboration agreement to enable interoperability between patient...
-
Oct 26, 2015Companies to Establish Interoperability between Hemodynamic Monitoring Systems and Infusion Devices
SAN DIEGO and IRVINE, Calif., October 23, 2015 – Edwards Lifesciences and CareFusion, a BD company, today announced a collaboration agreement to enable interoperability between patient...
-
Oct 6, 2015Study to be Presented at the American Society of Human Genetics 2015 Annual Meeting Demonstrates Applications for High-Resolution Gene Expression Studies
BALTIMORE and SAN JOSE, Calif., Oct. 6, 2015 – BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), today launched its first...
-
Oct 5, 2015
FRANKLIN LAKES, N.J., Oct. 05, 2015 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its participation in National Health...
-
Oct 4, 2015
FRANKLIN LAKES, N.J., Oct. 1, 2015 – BD(Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year 2015...
-
Oct 2, 2015
BALTIMORE, MD., Oct. 02, 2015 – BD Life Sciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Johns Hopkins University (JHU)...
-
Oct 1, 2015
FRANKLIN LAKES, N.J., Oct. 1, 2015 – BD(Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year 2015...
-
Sep 29, 2015FDA Updates March 2015 Safety Alert on CSTD Compatibility for Treanda® Injection
September 29, 2015 - Today BD (Becton, Dickinson and Company), notified customers that the U.S. Food and Drug Administration (FDA) has updated its March 2015 Safety Alert based on Teva...
-
Sep 24, 2015
SPARKS, MD., Sept. 24, 2015 – BD Life Sciences, a segment of global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), today announced the availability of the U.S. Food...
-
Sep 16, 2015Vyntus® WALK Wirelessly Assesses Functional Exercise Capacity
SAN DIEGO, CA, Sept. 16, 2015 – CareFusion, a BD company (NYSE: BDX), announces the availability of a new respiratory diagnostics tool that is a complete mobile solution for assessing functional...
-
Sep 15, 2015
CHICAGO, IL, Sept. 15, 2015 – The Product Development and Management Association (PDMA), the premier global advocate for product development and management professionals, announced today that it...
-
Sep 14, 2015
SEOUL, KOREA and BALTIMORE, MD, Sept. 14, 2015 – Seegene Inc. (096530.KQ) and BD Life Sciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX) today announced that they have entered...
-
Sep 3, 2015TechValidate Survey Supports Benefits of Pyxis ES Platform for Health System Pharmacy Operations
SAN DIEGO, CA, Sept. 3, 2015 – PRNewswire/ -- CareFusion, a BD company (NYSE: BDX), announces that its enterprise-level Pyxis® ES platform, developed to help hospitals and health systems better...
-
Aug 27, 2015Commitments include cash and product donations through AmeriCares, Direct Relief, Heart to Heart International, Project HOPE, Save the Children and UNICEF
FRANKLIN LAKES, N.J., Aug. 27, 2015 – BD (Becton, Dickinson and Company), a leading global medical technology company, has committed $700,000 in aid to assist those affected by the April 2015...
-
Aug 25, 2015
FRANKLIN LAKES, N.J., Aug. 25, 2015 – BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), today announced it has completed...
-
Aug 6, 2015- Announces adjusted revenues of $3.133 billion, an increase of 45.2 percent, or 55.6 percent on a currency-neutral basis. On a comparable, currency-neutral basis, adjusted revenues grew 2.4 percent. As reported, revenues of $3.120 billion increased 44.6 percent.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly adjusted revenues of $3.133 billion for the third fiscal quarter ended June...
-
Jul 28, 2015
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 60 cents per common share, payable on September 30, 2015 to holders of record on...
-
Jul 13, 20152014 Sustainability Report outlines new integrated strategy and goals to create more sustainable healthcare solutions
FRANKLIN LAKES, N.J., July 13, 2015 – BD(Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today an updated sustainability strategy and goals for...
-
Jun 27, 2015Results from independent analysis of survey of more than 600 hospitals presented today at the 42nd Annual APIC Conference
FRANKLIN LAKES, N.J. June 27, 2015 – BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that results from a new...
-
Jun 15, 2015BD expands its Massachusetts footprint with “Center of Excellence” to develop next generation technology for diabetes treatment
ANDOVER, MA, July 15, 2015 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, officially opened its Advanced Diabetes Care facility in Andover, Mass.,...
-
Jun 10, 2015WellSpan York Becomes First Hospital to Simultaneously Implement New Pumps and Interoperability to EHR
SAN DIEGO and YORK, Pa., June 10, 2015 /PRNewswire/ – WellSpan Health and CareFusion, a BD company (NYSE:BDX), today announced the successful implementation of the Alaris® System across all...
-
Jun 9, 2015CareFusion Has Most Organizations Live and Leads in Breadth of Functionality
CareFusion, a BD company (NYSE:BDX), today announced its Alaris® System intelligent infusion platform has been rated as the smart pump industry leader for interoperability with electronic medical...
-
Jun 8, 2015New Innovation Demonstrates Reductions in Flow Interruptions, Including Silent Occlusions
BD Medical, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), and Medtronic (NYSE: MDT) today announced a collaboration to introduce a new...
-
Jun 6, 2015
Studies Presented at the American Diabetes Association's 75(th) Scientific Sessions Demonstrate Potential Benefits of Proprietary Side-Ported Catheter BOSTON, June 6, 2015 /PRNewswire/ -- BD...
-
Jun 2, 2015Commits to Multiple Actions to Help Combat Antimicrobial Resistance
FRANKLIN LAKES, N.J.,June 02, 2015 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its participation in the White House Forum on...
-
May 27, 2015
CareFusion, a BD company (NYSE:BDX), provided an update on a global voluntary recall that was initiated on April 21, 2015 to address an issue with certain units of AVEA® ventilators. The recall...
-
May 13, 2015Unique Side-Ported Catheter Designed to Offer Consistent Insulin Delivery and Fewer Flow Interruptions including Silent Occlusions
FRANKLIN LAKES, N.J., May 13, 2015 – BD Medical, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), announced today it has received 510(k)...
-
May 5, 2015BD Medication & Procedural Solutions and Pharmaceutical Systems sites in Columbus push to close skills gap needed by local industry
COLUMBUS, NE, May 5, 2015 – BD Medical, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, has awarded $12,000 in scholarships to three local high...
-
May 4, 2015
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Bank of America Merrill Lynch 2015 Healthcare Conference on...
-
May 3, 2015
BD Announces Results for 2015 Second Fiscal Quarter View document online » PDF File of BD 2015 Second Fiscal Quarter Results » About BD BD is one of the largest global medical technology...
-
Apr 29, 2015
FRANKLIN LAKES, N.J., April 29, 2015 – BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that its BD Cato™...
-
Apr 22, 2015Program Champions Role of Diabetes Educators in Empowering Patients with Tips and Resources
FRANKLIN LAKES, N.J., April 22, 2015 – Diabetes is a complex disease that can often be overwhelming, creating barriers that may prevent people with diabetes from enjoying the same opportunities...
-
Apr 15, 2015System-wide Approach Integrates Health IT and Medication Management Platform
The Intelligent Hospital Association today announced that Ochsner Health System was awarded the Best Comprehensive Integration for 2014. The award is given to a hospital or health system that...
-
Apr 14, 2015Medication Management Technologies on Display at Intelligent Health Pavilion and Interoperability Showcase
CareFusion, a BD company (NYSE:BDX), today announced it is demonstrating several new medication management technologies at the Healthcare Information Management and Systems Society (HIMSS) annual...
-
Apr 8, 2015Medication Management, Interoperability, Cybersecurity Topics to Be Addressed
April 8, 2015 – CareFusion, a BD company (NYSE:BDX), today announced it will be hosting four presentations focused on medication management and safety topics at the 2015 Annual Conference of the...
-
Apr 6, 2015
BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its second fiscal quarter 2015 earnings conference call on Thursday, May 7, 2015, at 8:00 a.m....
-
Apr 2, 2015Joint development of BD Intelliport™ Medication Management System is the first step in the creation of new injection safety market
FRANKLIN LAKES, N.J., March 02, 2015 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the acquisition of CRISI Medical Systems, a...
-
Mar 20, 2015BD obtains CE Mark for the BD MAX™ CT/GC/TV and CT/GC assays, part of the BD Reproductive and Sexually Transmitted Infections portfolio
BALTIMORE, MD, March 20, 2015 – BD Life Sciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it obtained CE...